CategoryMedical & Pharma
American Society for Clinical Pharmacology/Therapeutics - ASCPT
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Society for Clinical Pharmacology/Therapeutics - ASCPT — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
ASCPT 2026 Annual Meeting (American Society for Clinical Pharmacology/Therapeutics)
The ASCPT 2026 Annual Meeting brings together influential clinical pharmacology and translational science professionals to advance the science and practice of developing therapies that improve outcomes for patients and society. The meeting is scheduled for March 4–6, 2026 and will take place in Denver, CO, United States.
As a key professional gathering for experts working across translational research and clinical drug development, the annual meeting focuses on strengthening the link between scientific discovery and real-world therapeutic impact. Attendees typically include leaders and specialists engaged in translational medicine, clinical pharmacology, regulatory science, and evidence generation—creating an environment designed for high-impact knowledge exchange, collaboration, and professional learning across the field.
Data sheet
American Society for Clinical Pharmacology/Therapeutics (ASCPT) – Event Attendee & Buyer Profile Analysis
Event date: March 31-April 2, 2027
Location: Anaheim Marriott, Anaheim, California, United States
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | American Society for Clinical Pharmacology/Therapeutics (ASCPT) Annual Meeting 2027 |
| Event Date | March 31-April 2, 2027 |
| Event Status | Upcoming |
| Venue | Anaheim Marriott |
| City | Anaheim |
| State / Region | California |
| Country | United States |
| Organizer | American Society for Clinical Pharmacology and Therapeutics (ASCPT) |
| Official Event Website | ascpt.org/Meetings/Annual-Meeting |
| Event Type | Association annual meeting, scientific conference, professional networking and education event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Education & Training |
| Audience Reach | National, with international scientific relevance |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Unconfirmed for 2027 in the source material reviewed |
| Main Purpose of Event | To convene clinical pharmacology and translational science professionals for research presentation, professional education, scientific collaboration, regulatory dialogue, and industry-academia-network engagement. |
About the Event
ASCPT is the annual meeting of the American Society for Clinical Pharmacology and Therapeutics, a professional society focused on advancing clinical pharmacology and translational medicine. Based on the official site content, the meeting serves scientists, physicians, drug development professionals, pharmacometricians, translational medicine leaders, regulatory science stakeholders, trainees, and industry participants working across therapeutic development and patient benefit.
For commercial teams, the event matters because it concentrates highly specialized decision-makers and influencers involved in biomarker strategy, precision medicine, pharmacogenomics, model-informed drug development, early development, regulatory science, outcomes, and translational informatics. It is best suited for B2B outreach into scientific platforms, clinical development services, regulatory support, data/analytics tools, bioinformatics, drug development technology, medical education, and research partnerships rather than high-volume mass-market lead capture.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical pharmacology leaders | Biopharma companies, research hospitals, academic medical centers | Influence scientific platform selection, study design, biomarker strategy, PK/PD tools, and external collaborations | High relevance for scientific software, CRO services, translational platforms, and consulting |
| Translational medicine and precision medicine teams | Drug developers, biotech firms, translational research groups | Evaluate biomarker, genomics, dosing, and patient stratification capabilities | Strong fit for diagnostics, bioinformatics, data platforms, and assay providers |
| Pharmacometrics and pharmacokinetics specialists | Biostatistics groups, model-informed drug development teams, academic labs | Recommend modeling software, simulation tools, and specialist service providers | High value for niche scientific technology suppliers |
| Regulatory science and outcomes professionals | Regulatory agencies, biopharma regulatory affairs teams, outcomes research groups | Shape evidence standards, submission readiness, and post-approval strategy | Relevant for regulatory consulting, real-world evidence, and medical writing providers |
| Drug safety and early development professionals | Pharmaceutical and biotechnology R&D organizations | Participate in vendor review for study support, analytics, safety technology, and outsourced expertise | Useful buyers for CRO, CDMO-adjacent, and analytics providers |
| Academic researchers and principal investigators | Universities, academic health systems, research institutes | Influence platform adoption, grant collaborations, and institutional pilots | Good fit for research tools, software, education, and sponsored collaboration offers |
| Government and public-health scientific stakeholders | Federal science and regulatory organizations | Influence standards, policy dialogue, and public-private scientific exchange | Relevant mainly for compliant scientific partnerships and thought leadership |
| Students, trainees, and early-career professionals | Graduate programs, fellowships, residency and training tracks | Lower direct purchasing authority but future pipeline influence | Best for brand building, education, and talent engagement |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Anaheim | Local venue-driven attendance from Southern California life sciences and academic communities | Medium | Convenient access for Orange County and greater Los Angeles participants |
| California | Strong draw from biotechnology, university research, and healthcare systems across the state | High | California is a major U.S. biopharma and translational research market |
| Nearby business hubs | Los Angeles, San Diego, Irvine, San Francisco Bay Area | High | Likely sources of pharma, biotech, CRO, and academic attendees |
| United States national reach | Attendees from major life sciences corridors such as Massachusetts, North Carolina, New Jersey, Pennsylvania, Maryland, and Texas | High | Likely attendee profile based on the society's national scientific role |
| International reach | Selective participation from global clinical pharmacology, translational medicine, and regulatory science communities | Medium | International component is likely, but 2027 country mix is not publicly confirmed in the reviewed material |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | ASCPT is a U.S.-based professional society and the annual meeting addresses clinical pharmacology and translational science across academia, industry, and regulatory stakeholders nationwide. |
| Secondary: International scientific relevance | Applicable | The subject matter and society scope suggest international professional interest, though 2027 international attendance is not confirmed in the reviewed source text. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| American Society for Clinical Pharmacology and Therapeutics (ASCPT) | Organizer / association | Confirmed organizer of the annual meeting and central network hub for members, scientific communities, and sponsors | ascpt.org | Meeting Director, Sponsorship Manager, Partnerships Director, Education Director | Confirmed Current-Year Participant |
| U.S. Food and Drug Administration (FDA) | Government / regulatory organization | Explicitly referenced on the ASCPT site through the ASCPT-FDA William Abrams Award Lecture, indicating formal relevance to the society's meeting ecosystem | fda.gov | Clinical Reviewer, Regulatory Science Lead, Pharmacometrics Team Lead, Scientific Program Manager | Confirmed Government / Procurement Organization |
| Current-year buyer company list not publicly released in reviewed sources | Data availability note | No official 2027 attendee, sponsor, exhibitor, or speaker organization list was available in the supplied source text | N/A | N/A | Confirmed limitation |
This event is suitable for targeted B2B attendee-list building only when supplemented by official program, speaker, sponsor, abstract, or exhibitor data as those become available. At present, verified company-level attendee intelligence for 2027 is limited in the reviewed source set.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | VP Clinical Pharmacology | R&D / Clinical Development | VP | Owns strategy and budgets for pharmacology programs and external scientific support |
| 2 | Director, Clinical Pharmacology | Clinical Development | Director | Core buyer/influencer for pharmacology tools, services, and collaborations |
| 3 | Head of Translational Medicine | Translational Science | Director / VP | Relevant for biomarker, precision medicine, and translational platform sales |
| 4 | Director, Pharmacometrics | Modeling & Simulation | Director | High-value target for modeling software and specialist services |
| 5 | PK/PD Scientist | Clinical Pharmacology | Manager / Individual Contributor | Technical evaluator and daily user of analysis platforms and external support |
| 6 | Director, Regulatory Science | Regulatory Affairs | Director | Important for evidence strategy, submission support, and compliance-related solutions |
| 7 | Director, Biomarkers / Translational Tools | Biomarkers / Precision Medicine | Director | Relevant for assay, omics, diagnostics, and translational data offers |
| 8 | Principal Investigator | Academic Research | Director / Professor | Influences research collaborations, software pilots, and institutional adoption |
| 9 | Scientific Program Manager | Research / Government | Manager / Director | Useful target in public-sector and collaborative scientific initiatives |
| 10 | Medical Affairs Director | Medical Affairs | Director | Relevant for scientific communication, evidence dissemination, and education vendors |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Direct alignment with clinical pharmacology, development, and translational medicine | Drug development services, PK/PD platforms, regulatory support |
| 2 | Biotechnology | High relevance for translational science, biomarkers, and precision medicine | Biomarker tools, genomics, data analytics, outsourced science |
| 3 | Research | Covers independent institutes and specialized scientific organizations | Research software, lab data workflows, collaborative programs |
| 4 | Higher Education | Academic medical and pharmacology research programs are core participants | Institutional pilots, education products, grants-related tools |
| 5 | Hospital & Health Care | Clinical investigators and translational care environments may participate | Clinical research platforms, precision dosing, patient-data tools |
| 6 | Medical Devices | Relevant where diagnostics, monitoring, and translational technology intersect | Companion diagnostics, data capture, clinical instrumentation |
| 7 | Information Technology & Services | Supports scientific data, translational informatics, and workflow tools | Scientific SaaS, analytics, compliance data systems |
| 8 | Computer Software | Fits pharmacometrics, modeling, simulation, and clinical analysis solutions | Modeling and simulation, scientific workflow automation |
| 9 | Government Administration | Applicable to public scientific and regulatory stakeholders | Public-sector scientific partnerships and regulatory dialogue |
| 10 | Health, Wellness & Fitness | Secondary fit for precision-health and dosing-adjacent innovation providers | Digital health solutions with strong clinical evidence orientation |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Reviewed official page content | No 2027 attendance number found in supplied official text |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Reviewed official page content | No exhibitor directory reviewed |
| Buyer count | Not publicly confirmed | Unconfirmed | Reviewed official page content | Meeting is association/scientific in nature rather than a buyer-hosted procurement fair |
| Speaker count | Not publicly confirmed | Unconfirmed | Reviewed official page content | Agenda and faculty roster were not present in the supplied extract |
| Sponsor count | Not publicly confirmed | Unconfirmed | Reviewed official page content | No sponsor page reviewed |
| Historical attendance | Not available in reviewed sources | Historical data unavailable | Reviewed official page content | No prior-year attendance statistic identified in the supplied text |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical pharmacology | Dose optimization, PK/PD interpretation, development decision support | Scientific demos, expert consultations, case-study-led outreach | Modeling tools, pharmacology consulting, analytics platforms |
| Translational medicine | Bridge discovery to clinic with robust data and biomarker insight | Partnership discussions and pilot-project proposals | Biomarker platforms, translational assays, scientific data integration |
| Pharmacometrics & pharmacokinetics | Simulation accuracy, workflow efficiency, scalable analysis | Hands-on software evaluation and technical workshops | Modeling software, cloud compute environments, specialist service teams |
| Precision medicine | Patient stratification, pharmacogenomics, targeted dosing | Targeted solution mapping by therapeutic area | Genomics tools, companion diagnostics, precision dosing software |
| Regulatory science | Evidence quality, submission-readiness, scientific validation | Regulatory-focused thought leadership and advisory positioning | Regulatory consulting, documentation support, data integrity solutions |
| Drug utilization & outcomes | Real-world evidence and treatment impact assessment | Outcomes analytics positioning and payer-evidence discussions | RWE analytics, data partnerships, HEOR support |
| Translational informatics | Data integration, computational analysis, cross-functional visibility | Platform walkthroughs and interoperability discussions | Data engineering, research informatics, workflow automation |
| Education and career development | Continuing education, scientific training, talent pipeline | Brand building through education and trainee engagement | Training platforms, scientific publishing, recruitment marketing |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Good fit for specialized medical, scientific, data, and drug-development solutions |
| Decision-maker availability | Medium | Senior scientific leaders likely attend, but many participants may be technical evaluators rather than pure procurement owners |
| Data collection potential | Medium | Useful if official speaker, abstract, sponsor, or attendee data becomes available; currently limited in reviewed sources |
| Apollo targeting potential | Very High | Apollo can effectively target pharma, biotech, academic research, translational science, and regulatory-adjacent personas |
| Geographic targeting potential | High | Can be focused around U.S. life sciences corridors, especially California and major pharma hubs |
| Best outreach approach | High | Thought-leadership-led outreach, scientific use-case messaging, meeting follow-up, and abstract/speaker mapping |
| Overall lead quality | High | High-value niche audience; quality over volume |
| Best use case | High | Account-based targeting, scientific solution sales, partnership outreach, and conference-based relationship building |
| Limitations / risks | Medium | Current-year public participant data is limited; scientific attendees may require longer consultative sales cycles |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Research; Higher Education; Hospital & Health Care; Medical Devices; Information Technology & Services; Computer Software; Government Administration | Concentrate on organizations most aligned with clinical pharmacology and translational medicine |
| Departments | Research; Engineering; Information Technology; Medical & Health; Operations; Business Development; Education | Capture both scientific evaluators and partnership decision-makers |
| Seniority | Director; VP; Head; CXO; Manager; Partner; Owner; Professor-level equivalents where available | Prioritize budget holders and scientific influencers |
| Job titles | Clinical Pharmacology Director; VP Clinical Pharmacology; Head of Translational Medicine; Director Pharmacometrics; PK/PD Scientist; Director Regulatory Science; Biomarker Director; Principal Investigator; Medical Affairs Director; Scientific Program Manager | Build precision lists around the most relevant functions |
| Geography | United States first; priority states: California, Massachusetts, New Jersey, Pennsylvania, Maryland, North Carolina, Texas | Align with major U.S. life sciences corridors likely represented at ASCPT |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,001+ | Covers venture-backed biotech through global pharma and large research institutions |
| Keywords | clinical pharmacology; translational medicine; pharmacometrics; PK/PD; precision medicine; pharmacogenomics; biomarker; regulatory science; drug safety; translational informatics; quantitative pharmacology | Find role and company profiles aligned with the event's scientific themes |
| Technologies, if relevant | Clinical data platforms; bioinformatics; statistical computing; modeling and simulation stacks | Useful for software and infrastructure sellers |
| Revenue range, if relevant | $10M-$50M; $50M-$100M; $100M-$500M; $500M-$1B; $1B+ | Separate emerging biotech from enterprise pharma accounts |
| Company type | Public companies; private companies; nonprofits; academic institutions; government organizations | Reflects the mixed attendee base typical of ASCPT |
Suggested Apollo Search Logic: ("clinical pharmacology" OR pharmacometrics OR "translational medicine" OR PKPD OR "precision medicine" OR pharmacogenomics OR biomarker OR "regulatory science") AND (Director OR VP OR Head OR Principal OR Scientist) AND (Pharmaceuticals OR Biotechnology OR Research OR Higher Education OR Hospital & Health Care).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ASCPT Annual Meeting page | Official organizer website | Confirmed existence of ASCPT Annual Meeting; confirmed 2026 edition reference; confirmed 2027 Annual Meeting mention; confirmed 2027 call for abstracts; confirmed scientific focus areas and society communities | High |
| ASCPT Home page | Official organizer website | Verified organization identity, mission, and focus on clinical pharmacology and translational medicine | High |
| User-provided event brief | User-supplied planning input | Used for 2027 dates and venue/location details because these were not visible in the supplied official page text extract | Medium |
| Verification note | Research limitation | No official 2027 attendee list, speaker roster, exhibitor directory, sponsor list, or attendance figure was available in the supplied source text. Company-level participation intelligence should be updated when official 2027 program materials are published. | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Society for Clinical Pharmacology/Therapeutics - ASCPT — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds